CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 63 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $222,000 | – | 13,401 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,912,345 | 41.46% |
Perceptive Advisors | 6,511,727 | $205,379,869 | 5.77% |
Finepoint Capital LP | 517,287 | $16,315 | 5.28% |
Artal Group S.A. | 1,900,000 | $59,926 | 3.34% |
Affinity Asset Advisors, LLC | 215,000 | $6,781,100 | 2.66% |
Rock Springs Capital Management LP | 2,506,464 | $79,053,875 | 1.90% |
Hood River Capital Management LLC | 923,638 | $29,131,543 | 1.06% |
Logos Global Management LP | 260,000 | $8,200,400 | 0.96% |
Frazier Life Sciences Management, L.P. | 393,000 | $12,395,220 | 0.77% |
FEDERATED HERMES, INC. | 2,867,451 | $90,439,405 | 0.25% |